Pursuing enigmas on ischemic heart disease and sudden cardiac death

Ken-ichi Yoshida1

  • 1Department of Forensic Medicine, Graduate School of Medicine and School of Public Health, University of Tokyo, Bunkyo-ku, Tokyo, Japan. kyoshida@m.u-tokyo.ac.jp

Insights

This review explores how calcium-dependent protease calpain causes heart cell death during ischemia. It also covers stress-induced hypertension and the protective effects of carbon monoxide on cardiac cells against ischemia-reperfusion injury.

Area of Science:

  • Cardiovascular Science
  • Cellular Biology
  • Biochemistry

Background:

  • Ischemic injury leads to myocardial cell death.
  • Calpain, a calcium-dependent protease, plays a role in this process.
  • Intracellular signaling pathways are involved in compensatory responses.

Purpose of the Study:

  • To review the mechanisms of ischemic injury in the myocardium.
  • To explore compensatory responses involving signaling molecules.
  • To investigate the effects of psychological stress on cardiovascular health.
  • To highlight the cardioprotective role of carbon monoxide.

Main Methods:

  • Review of existing research findings.
  • Analysis of intracellular signaling pathways (PKC, MAP kinase, PI3 kinase).
  • Examination of stress-induced cardiovascular responses.
  • Investigation of carbon monoxide's effects on ischemia-reperfusion injury.

Main Results:

  • Ischemic injury involves Ca(2+)-dependent protease calpain.
  • Compensatory responses are mediated by PKC, MAP kinase, and PI3 kinase.
  • Psychological stress can induce hypertension and alter cardiovascular signaling.
  • Carbon monoxide unexpectedly demonstrates protective effects against ischemia-reperfusion injury.

Conclusions:

  • Calpain activation is a key factor in myocardial ischemic injury.
  • Signaling molecules mediate cellular responses to ischemia and stress.
  • Carbon monoxide offers a novel protective strategy for the heart against ischemic damage.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...